CLZR Candela (MM)

Candela Corporation (NASDAQ:CLZR) today announced that it has received registration approval from the Brazilian National Health Surveillance Agency (ANVISA) to market the Candela Alex TriVantage® multi-wavelength, q-switched laser system in Brazil.

“Until now, providing high quality and effective treatment for pigmented lesions and multi-color tattoos meant that Brazilian doctors needed to own at least two different lasers. With Alex TriVantage’s Laser-Pumped-Laser (LPL) technology, a greater number of doctors will be able to offer a wider variety of services assured of the ability to provide treatment regardless of the patient’s skin color,” said Candela President and Chief Executive Officer, Gerard E. Puorro. “This approval increases the number of Candela products marketed in Brazil, enabling us to offer a more complete range of highly effective aesthetic laser solutions.”

Unique, q-switched Laser-Pumped-Laser (LPL) technology provides 755 nm, 532 nm and 1064 nm output wavelengths, making Alex TriVantage extremely versatile. The addition of a long-pulse mode at 755nm offers advanced treatments for a wider variety of pigmented lesions without side effects. Beyond the treatment of benign pigmented lesions and the removal of multi-color tattoo inks, Alex TriVantage enhances the results of many skin rejuvenation treatments, making it an ideal system for optimizing fractional and other rejuvenation treatment results.

The Alex TriVantage platform has received wide acclaim including a recent feature on ABC’s nationally broadcasted “The View”. To see dermatologist Suzanne Kilmer, MD from Sacramento, CA performing a tattoo removal treatment, visit Candela’s website at www.candelalaser.com/theview.

For more information, contact jane.smith@candelalaser.com or visit www.alextrivantage.com. To speak to our representative in Brazil, contact Edson Veiga at edson@medson.com.br or 55-21-2431-5577.

About CANDELA: Candela Corporation manufactures and distributes innovative clinical solutions that enable physicians, surgeons, and personal care practitioners to treat selected cosmetic and medical conditions using lasers, aesthetic laser systems, and other advanced technologies. Founded near Boston in 1970, Candela markets and services its products in 86 countries from offices and distributors in the United States, Europe, Japan, China and other Asian locations. Candela established the aesthetic laser market 20 years ago, and currently has an installed base of over 13,500 systems worldwide. Visit Candela on the Web at http://www.candelalaser.com.

Safe Harbor Statement: Except for the historical information contained herein, this news release contains forward-looking statements that constitute Candela Corporation’s current intentions, hopes, beliefs, expectations or predictions of the future, which are therefore inherently subject to risks and uncertainties. These statements include declarations regarding our or our management’s beliefs and current expectations. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential” or “continue” or the negative of such terms or other comparable terminology. These forward-looking statements are subject to inherent risks and uncertainties in predicting future results and conditions that could cause the actual results to differ materially from those projected in these forward-looking statements. The risks and uncertainties that may affect forward-looking statements include, among others: the availability of, and our ability to successfully implement strategic and operational alternatives, the pendency of re-examinations of the ‘844 Patent and the ‘568 Patent before the PTO, our alleged infringement of the ‘844 Patent and the ‘568 Patent, the validity of the ‘844 Patent and the ‘568 Patent, our expected legal expenses, our exploration of strategic and operational alternatives, the expected recovery of our industry, our future revenue, gross margin, expense levels and earnings, our growth prospects, market acceptance of our products, the strength of our distribution channels, our ability to add new products, our ability to expand regulatory approvals and the liquidity of our common stock, the cancellation or deferral of customer orders, the risk of a material adverse judgment or increased litigation-related expenses in pending litigation matters, dependence on a small number of strategic distribution relationships, difficulties in the timely development and market acceptance of new products, unanticipated increases in expenses, market developments that vary from the current public expectations concerning the growth of the laser industry, increased competitive pressures, changes in economic conditions, or difficulties in obtaining timely regulatory approvals. Further information on factors that could affect Candela's performance is included in Candela's periodic reports filed with the SEC. Candela cautions readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Candela expressly disclaims any obligations or undertaking to release publicly any updates or revisions to any such statements to reflect any change in Candela's expectations or any change in events, conditions or circumstances on which any such statement is based.

Photos/Multimedia Gallery Available: http://www.businesswire.com/cgi-bin/mmg.cgi?eid=6018178&lang=en

Candela (MM) (NASDAQ:CLZR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024

Candela (MM) (NASDAQ:CLZR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024